News Search Results
Mar 19, 2025, 09:15 ET REGENXBIO REPORTS POSITIVE BIOMARKER DATA FROM AFFINITY DUCHENNE® TRIAL OF RGX-202 GENE THERAPY
and independence, required support for breathing, cardiomyopathy and premature death. ABOUT REGENXBIO Inc.REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field
More news about: REGENXBIO Inc.
Mar 19, 2025, 09:00 ET InSysBio announces its collaboration with discoveric bio alpha
InSysBio, one of the world's pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces its collaboration with discoveric bio alpha, a biotechnology company taking next generation antibody technologies into Alzheimer's Disease.
More news about: InSysBio
Mar 19, 2025, 07:15 ET Patricia Industries' subsidiary Advanced Instruments to acquire and merge with Nova Biomedical
a manufacturer of innovative analytical instruments and consumables that are vital in guiding the treatment of patients and the development of biotechnology therapeutics.
More news about: Advanced Instruments, LLC
Mar 19, 2025, 07:00 ET Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH
proceedings continue. This ruling reinforces Zymo Research's commitment to protecting scientific innovation and ensuring fair competition in the biotechnology sector. As proceedings continue, the company remains focused on delivering cutting-edge sample preparation technologies to the biomedical community
More news about: Zymo Research Corp.
Mar 19, 2025, 07:00 ET Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH
proceedings continue. This ruling reinforces Zymo Research's commitment to protecting scientific innovation and ensuring fair competition in the biotechnology sector. As proceedings continue, the company remains focused on delivering cutting-edge sample preparation technologies to the biomedical community
More news about: Zymo Research Corp.
Mar 19, 2025, 07:00 ET ELIAS Animal Health Receives Full Approval from USDA for the ELIAS Cancer Immunotherapy (ECI®), First-In-Class Treatment for Canine Osteosarcoma
www.eliasanimalhealth.com. About ELIAS Animal Health ELIAS Animal Health is a medical biotechnology company focused on advancing a pipeline of immunotherapies, including an adoptive cell therapy and an oncolytic virotherapy, for the treatment of
More news about: ELIAS Animal Health
Mar 19, 2025, 06:00 ET Future Origins and Kao Enter Purchase Agreement for Palm Alternative NALO™
Kao Senior Executive Officer in charge of Chemical Business. Future Origins was founded by industrial biotechnology leader Geno, together with Unilever, Kao, and L'Oréal, to commercialize and manufacture high-volume sustainable ingredients for widely used surfactants
More news about: Future Origins
Mar 19, 2025, 02:56 ET Global Times: Xi inspects Guizhou, stresses high-quality development
Emerging industries in Southwest China's Sichuan, including artificial intelligence, biotechnology, drones, and nuclear technology applications, have experienced rapid growth."As an important part of the western region,
More news about: Global Times
Mar 18, 2025, 17:39 ET DarwinHealth Recognized and Honored as One of the Top 10 Most Innovative Biotech Companies: Named to Fast Company's Prestigious Annual List of the World's Most Innovative Companies of 2025
forward." About DarwinHealth DarwinHealth: Precision Therapeutics for Cancer Medicine is a clinical grade, "frontiers of cancer," biotechnology-focused company, co-founded by CEO Gideon Bosker, MD, and Professor Andrea Califano,
More news about: DarwinHealth
Mar 18, 2025, 17:19 ET DarwinHealth Recognized and Honored as One of the Top 10 Most Innovative Biotech Companies: Named to Fast Company's Prestigious Annual List of the World's Most Innovative Companies of 2025
forward." About DarwinHealth DarwinHealth: Precision Therapeutics for Cancer Medicine is a clinical grade, "frontiers of cancer," biotechnology-focused company, co-founded by CEO Gideon Bosker, MD, and Professor Andrea Califano,
More news about: DarwinHealth
Mar 18, 2025, 16:05 ET INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
MEETING, Pa., March 18, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious
More news about: INOVIO Pharmaceuticals, Inc.
Mar 18, 2025, 16:00 ET Oracle and NVIDIA Collaborate to Help Enterprises Accelerate Agentic AI Inference
or at the edge. This offering provides an integrated AI stack to help address data privacy, sovereign AI, and low-latency requirements. Biotechnology company Soley Therapeutics is deploying OCI AI infrastructure, NVIDIA AI Enterprise, and NVIDIA Blackwell GPUs to build its AI drug discovery platform
More news about: Oracle
Mar 18, 2025, 12:13 ET Insecticides Market To Reach USD 12.4 Billion By 2030, Growing At A 4.80% CAGR - Credence Research
https://www.credenceresearch.com/report/crop-protection-chemicals-market Agriculture Biotechnology Market - https://www.credenceresearch.com/report/agriculture-biotechnology-market Follow Us:
More news about: Credence Research Inc.
Mar 18, 2025, 10:01 ET Central Lab Services Market worth US$8.18 billion by 2030with 6.5% CAGR | MarketsandMarkets™
ICON plc (Ireland): ICON plc offers outsourced drug development services to the pharmaceutical, biotechnology, and medical device industries. The company provides clinical, consulting, and commercial services ranging from trial design to post-market commercialization.
More news about: MarketsandMarkets
Mar 18, 2025, 09:00 ET Ninth Annual "Feeding the Economy" Report Demonstrates Immense Impact of the American Food and Agriculture Industry Amidst Economic Challenges
Frozen Food InstituteAmerican Peanut CouncilAmerican Soybean AssociationAssociation of Equipment ManufacturersBiotechnology Innovation OrganizationConsumer Brands AssociationCorn Refiners AssociationCropLife AmericaEdible Oil Producers
More news about: Food and Agriculture Industry Organizations
Mar 18, 2025, 08:03 ET TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead
March 18, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced initiatives to outsource several
More news about: TC BioPharm
Mar 18, 2025, 08:00 ET Japanese-Founded Regulatory T-cell Reprogramming Company RegCell Secures $45.8M in Funding and Completes U.S. Headquarters Transition
EMERYVILLE, Calif., March 18, 2025 /PRNewswire/ -- RegCell, Inc., a biotechnology company developing first-in-class therapies for autoimmune diseases and transplantation with its epigenetic reprogramming platform leveraging the
More news about: RegCell, Inc.
Mar 18, 2025, 08:00 ET Tecsys Expands Global Reach with Roche's Adoption of Elite™ for Laboratory Inventory Management
Tecsys Inc. (TSX: TCS), a global leader in supply chain management solutions, announced that Roche, the world's largest biotechnology company and global leader in in-vitro diagnostics, has selected Tecsys' Elite™ platform for implementation across Roche's network of core laboratory
More news about: Tecsys Inc.
Mar 18, 2025, 08:00 ET Tecsys Expands Global Reach with Roche's Adoption of Elite™ for Laboratory Inventory Management
Tecsys Inc. (TSX: TCS), a global leader in supply chain management solutions, announced that Roche, the world's largest biotechnology company and global leader in in-vitro diagnostics, has selected Tecsys' Elite™ platform for implementation across Roche's network of core laboratory
More news about: Tecsys Inc.
Mar 18, 2025, 07:30 ET Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes
March 18, 2025 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, announced today that it has started enrolling patients into
More news about: Virax Biolabs
Mar 18, 2025, 05:45 ET ICON Public Limited Company Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 11, 2025 to Discuss Your Rights - ICLR
insufficient to shield the Company from the adverse effects of a significant market downturn; (c) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: Levi & Korsinsky, LLP
Mar 18, 2025, 04:00 ET Cipla and Formosa sign multi-regional licensing deal for Clobetasol Suspension
throughout its term. About Formosa Pharmaceuticals, Inc. Formosa Pharmaceuticals, Inc. (6838.TW) is a clinical stage biotechnology company with primary focus in the areas of ophthalmology and oncology. The company's proprietary nanoparticle formulation technology (APNT®),
More news about: Formosa Pharmaceuticals Inc.,
Mar 17, 2025, 18:00 ET TaiMed Biologics Announces Results from Late-Breaking Phase 2a Data on Long-Acting HIV Maintenance Therapy at CROI 2025
[email protected]. About TaiMed Biologics Founded in 2007, TaiMed Biologics (4147.TWO) is a leading commercial-stage biotechnology company focused on developing innovative therapies for HIV treatment. The company successfully launched ibalizumab (Trogarzo®), the world's first
More news about: TaiMed Biologics
Mar 17, 2025, 18:00 ET TaiMed Biologics Announces Results from Late-Breaking Phase 2a Data on Long-Acting HIV Maintenance Therapy at CROI 2025
[email protected]. About TaiMed Biologics Founded in 2007, TaiMed Biologics (4147.TWO) is a leading commercial-stage biotechnology company focused on developing innovative therapies for HIV treatment. The company successfully launched ibalizumab (Trogarzo®), the world's first
More news about: TaiMed Biologics
Mar 17, 2025, 17:31 ET VITRAKVI Maintains Market Leadership Across the 7MM Amid Growing TRK Inhibitor Competition | DelveInsight
namely, DOVBLERON (taletrectinib/AB-106/IBI-344) (Nuvation Bio/Innovent Biologics/Daiichi Sankyo/Nippon Kayaku) and ANS03 (Avistone Biotechnology), being evaluated for NSCLC. Taletrectinib (AB-106/IBI-344) is a next-generation, selective ROS1 inhibitor designed for treating advanced
More news about: DelveInsight Business Research, LLP